Search
for
Sort by
Research 301–330 of 1000+
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Regulatory roles of androgens in cutaneous wound healing
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
- Idiopathic Hirsutism*
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Novel agents for the treatment of alopecia
- New approaches to the treatment of osteoporosis
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- The Hirsute Woman: Challenges in Evaluation and Management
- Hormonal Parameters in Androgenetic Hair Loss in the Male
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- CLINICAL UPDATES IN HAIR
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Female Androgenic Alopecia
- Synthesis and Pharmacological Evaluation of New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Dual inhibitors of urease and carbonic anhydrase-II from <i>Iris</i> species